$25bn-plus trade sharpens pharma giants’ focus
Friday, April 25, 2014 - 08:50
in Mathematics & Economics
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via